API Product   :    Levetiracetam
CEP   :    -
WCC   :    -
Therapeutic Use    :    All Other Therapeutic Products; Anti-Epileptics
All Other Therapeutic Products; Anti-Epileptics
Originator   :    HQ Specialty Pharma
HQ Specialty Pharma
CAS No.    :    170.209 g/mol
Trade Name.   :    KEPPRA
Molecular Weight   :    170.209 g/mol
Molecular Formula   :    C8H14N2O2
Levetiracetam is an anticonvulsant used in combination with other medications to treat seizure disorders (epilepsy). Levetiracetam has been shown to decrease the number of seizures in adults and children. It is not known how it works to prevent seizures.
Levetiracetam, marketed under the trade name Keppra among others, is a medication used to treat epilepsy. It is used for partial onset, myoclonic, or tonic-clonic seizures. It is taken by mouth as an immediate release or extended release formulation or by injection into a vein. Common side effects include sleepiness, dizziness, feeling tired, and aggression. Severe side effects may include psychosis, suicide, and allergic reactions such as Stevens-Johnson syndrome and anaphylaxis. It is the S-enantiomer of etiracetam.